在现实世界中对核心结合因子急性髓性白血病的临床特征和预后因素分析
Yamei Zhai1, Qingya Wang1, Li Ji1
1Department of Hematology, Peking University First Hospital, Beijing, China.
Cancer medicine
|December 8, 2023
概括
核心结合因子急性髓性白血病 (CBF-AML) 的预后比欧洲白血病网络 (ELN) 的指导方针建议的要差. 这项研究突出了不同的亚型,并确定了在CBF-AML患者中更好的风险分层的关键预后因素.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 核心结合因子 (CBF) 基因转位与中国15%的成年急性髓性白血病 (AML) 有关.
- 尽管欧洲白血病网络 (ELN) 对CBF-AML的风险分类有利,但其复发率高达40%.
研究的目的:
- 分析CBF-AML的临床特征和预后.
- 为了比较CBF-AML中的inv(16) 和t(8;21) 亚型.
- 验证影响CBF-AML结果的预后因素.
主要方法:
- 从2012年3月到2022年3月对149名AML患者 (75名CBF-AML,74名非CBF) 的回顾性分析.
- 在CBF-AML和非CBFAML队列之间比较临床特征,遗传突变和生存结果.
- 多变量分析以确定独立的预后因素.
主要成果:
- 与非CBF AML相比,CBF-AML患者的无病生存期 (DFS) 显著降低,非复发死亡率 (NRM) 较高.
- 在inv(16) 和t(8;21) 亚型之间观察到明显的同时发生的基因突变模式,其中inv(16) 与中枢神经系统 (CNS) 白血病的风险增加有关.
- 年龄,酶突变和WT1突变被确定为特定CBF-AML亚型的整体存活 (OS),DFS和NRM的显著预后因素.
- 同源性造血干细胞移植 (allo-HSCT) 显示出对低风险的AML的预后有潜在的益处.
结论:
- 对CBF-AML的预后似乎比目前ELN指导方针所建议的更差.
- 这两种类型代表着不同的实体,需要量身定制的风险分层策略.
- 需要进一步的研究来证实alo-HSCT在低风险t(8;21) AML中的好处,并完善预后模型.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Factors Affecting Protein-Drug Binding: Protein-Related Factors
167
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
167
Bone Marrow Sampling and Transplants
333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K


